These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 18438416)

  • 1. CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells.
    Perruche S; Zhang P; Liu Y; Saas P; Bluestone JA; Chen W
    Nat Med; 2008 May; 14(5):528-35. PubMed ID: 18438416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes.
    Belghith M; Bluestone JA; Barriot S; Mégret J; Bach JF; Chatenoud L
    Nat Med; 2003 Sep; 9(9):1202-8. PubMed ID: 12937416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery from experimental allergic encephalomyelitis is TGF-beta dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells.
    Zhang X; Reddy J; Ochi H; Frenkel D; Kuchroo VK; Weiner HL
    Int Immunol; 2006 Apr; 18(4):495-503. PubMed ID: 16540527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells.
    Ochi H; Abraham M; Ishikawa H; Frenkel D; Yang K; Basso AS; Wu H; Chen ML; Gandhi R; Miller A; Maron R; Weiner HL
    Nat Med; 2006 Jun; 12(6):627-35. PubMed ID: 16715091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated human CD4+ T cells induced by dendritic cell stimulation are most sensitive to transforming growth factor-beta: implications for dendritic cell immunization against cancer.
    Lin CM; Wang FH; Lee PK
    Clin Immunol; 2002 Jan; 102(1):96-105. PubMed ID: 11781072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential roles of TGF-beta in anti-CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells.
    Chen G; Han G; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y
    J Leukoc Biol; 2008 Feb; 83(2):280-7. PubMed ID: 18029395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice.
    Steffens S; Burger F; Pelli G; Dean Y; Elson G; Kosco-Vilbois M; Chatenoud L; Mach F
    Circulation; 2006 Oct; 114(18):1977-84. PubMed ID: 17043169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.
    Sasaki N; Yamashita T; Takeda M; Shinohara M; Nakajima K; Tawa H; Usui T; Hirata K
    Circulation; 2009 Nov; 120(20):1996-2005. PubMed ID: 19884470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epicutaneously induced TGF-beta-dependent tolerance inhibits experimental autoimmune encephalomyelitis.
    Szczepanik M; Tutaj M; Bryniarski K; Dittel BN
    J Neuroimmunol; 2005 Jul; 164(1-2):105-14. PubMed ID: 15899524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD3-specific antibody-induced active tolerance: from bench to bedside.
    Chatenoud L
    Nat Rev Immunol; 2003 Feb; 3(2):123-32. PubMed ID: 12563296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta1 inhibits protracted-relapsing experimental autoimmune encephalomyelitis by activating dendritic cells.
    Jin YX; Xu LY; Guo H; Ishikawa M; Link H; Xiao BG
    J Autoimmun; 2000 May; 14(3):213-20. PubMed ID: 10756083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of nuclear factor-kappa B enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis.
    Iruretagoyena MI; Sepúlveda SE; Lezana JP; Hermoso M; Bronfman M; Gutiérrez MA; Jacobelli SH; Kalergis AM
    J Pharmacol Exp Ther; 2006 Jul; 318(1):59-67. PubMed ID: 16597709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CD3-specific antibody-induced T-cell apoptosis and apoptotic cell uptake lead to CD3-specific antibody-induced tolerance].
    Perruche S; Saas P
    Med Sci (Paris); 2009 Apr; 25(4):325-7. PubMed ID: 19409176
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of reactive nitrogen intermediates and transforming growth factor-beta produced by immunosuppressive macrophages in the expression of suppressor activity against T cell proliferation induced by TCR stimulation.
    Shimizu T; Cai S; Tomioka H
    Cytokine; 2005 Apr; 30(1):7-13. PubMed ID: 15784407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
    Ellestad KK; Tsutsui S; Noorbakhsh F; Warren KG; Yong VW; Pittman QJ; Power C
    J Immunol; 2009 Jul; 183(1):298-309. PubMed ID: 19542441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody.
    Ishikawa H; Ochi H; Chen ML; Frenkel D; Maron R; Weiner HL
    Diabetes; 2007 Aug; 56(8):2103-9. PubMed ID: 17456848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens.
    Miyake Y; Asano K; Kaise H; Uemura M; Nakayama M; Tanaka M
    J Clin Invest; 2007 Aug; 117(8):2268-78. PubMed ID: 17657313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for TGF-beta in the suppression by murine bronchoalveolar cells of lung dendritic cell initiated immune responses.
    Lipscomb MF; Pollard AM; Yates JL
    Reg Immunol; 1993; 5(3-4):151-7. PubMed ID: 8240933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta as a promising option in the treatment of multiple sclerosis.
    Mirshafiey A; Mohsenzadegan M
    Neuropharmacology; 2009; 56(6-7):929-36. PubMed ID: 19285095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.